BRPI0520622B8 - processo para o preparo de conjugados de insulina - Google Patents

processo para o preparo de conjugados de insulina

Info

Publication number
BRPI0520622B8
BRPI0520622B8 BRPI0520622A BRPI0520622A BRPI0520622B8 BR PI0520622 B8 BRPI0520622 B8 BR PI0520622B8 BR PI0520622 A BRPI0520622 A BR PI0520622A BR PI0520622 A BRPI0520622 A BR PI0520622A BR PI0520622 B8 BRPI0520622 B8 BR PI0520622B8
Authority
BR
Brazil
Prior art keywords
insulin
oligomer
precursor
conjugate
insulin conjugates
Prior art date
Application number
BRPI0520622A
Other languages
English (en)
Inventor
Khedkar Anand
Goel Anuj
Krishnan Gautam
Sachdev Goldy
Manikam Govindasamy
S Manjunath H
Iyer Harish
Garg Mayank
Roy Nita
Dave Nitesh
Hazra Partha
Suryanarayan Shrikumar
Original Assignee
Biocon Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocon Ltd filed Critical Biocon Ltd
Publication of BRPI0520622A2 publication Critical patent/BRPI0520622A2/pt
Publication of BRPI0520622B1 publication Critical patent/BRPI0520622B1/pt
Publication of BRPI0520622B8 publication Critical patent/BRPI0520622B8/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/62Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

processo para o preparo de conjugados de insulina. a presente invenção refere-se a um processo para produção de in-105, conjugado insulina-oligômero. o precursor da in-105 tendo a fórmula g-a-v-r-[cadeia b]-r-d-a-d-d-r-[cadeia a] é clonado e expresso em pichia. o precursor biossintético é, em seguida, conjugado a um oligômero ativado. o conjugado precursor da in-105-oligômero é tratado, em seguida, com protease e purificado para dar origem ao conjugado ativo insulina-oligômero da fórmula insulina-oc-ch2-ch2-(och2ch2)3-och3.
BRPI0520622A 2005-10-13 2005-10-13 processo para o preparo de conjugados de insulina BRPI0520622B8 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IN2005/000338 WO2007043059A1 (en) 2005-10-13 2005-10-13 Process for the preparation of insulin conjugates.

Publications (3)

Publication Number Publication Date
BRPI0520622A2 BRPI0520622A2 (pt) 2009-05-19
BRPI0520622B1 BRPI0520622B1 (pt) 2021-04-13
BRPI0520622B8 true BRPI0520622B8 (pt) 2021-05-25

Family

ID=37942365

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0520622A BRPI0520622B8 (pt) 2005-10-13 2005-10-13 processo para o preparo de conjugados de insulina

Country Status (13)

Country Link
US (1) US8058391B2 (pt)
EP (1) EP1934252B1 (pt)
JP (1) JP5047978B2 (pt)
KR (1) KR101269540B1 (pt)
CN (1) CN101291952B (pt)
BR (1) BRPI0520622B8 (pt)
DK (1) DK1934252T3 (pt)
ES (1) ES2546016T3 (pt)
IL (1) IL190666A (pt)
MX (1) MX2008004674A (pt)
PL (1) PL1934252T3 (pt)
PT (1) PT1934252E (pt)
WO (1) WO2007043059A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11361853B2 (en) 2002-10-29 2022-06-14 Practice Velocity, LLC Method and system for automated medical records processing with telemedicine
CA2822302A1 (en) 2006-02-13 2007-08-23 Alethia Biotherapeutics Inc. Methods of impairing osteoclast differentiation
US8168181B2 (en) 2006-02-13 2012-05-01 Alethia Biotherapeutics, Inc. Methods of impairing osteoclast differentiation using antibodies that bind siglec-15
WO2008049711A1 (en) 2006-10-27 2008-05-02 Novo Nordisk A/S Peptide extended insulins
US8802816B2 (en) * 2008-02-19 2014-08-12 Biocon Limited Method of obtaining a purified, biologically active heterologous protein
KR20110059602A (ko) * 2008-08-07 2011-06-02 바이오콘 리미티드 인슐린 화합물의 제조방법
EP2451824A4 (en) * 2009-07-09 2013-04-24 Biocon Ltd PREPARATIVE NONLINEAR CHROMATOGRAPHIC PROCESSING ON GRADIENT BASIS AND CLEANED PRODUCTS THEREOF
UY33326A (es) 2010-04-14 2011-12-01 Sanofi Aventis Conjugados de insulina-sirna
US9457096B2 (en) 2012-07-06 2016-10-04 Consejo Nacional De Investigaciones Cientificas Y Tecnicas (Concet) Protozoan variant-specific surface proteins (VSP) as carriers for oral drug delivery
ES2723885T3 (es) 2012-07-19 2019-09-03 Daiichi Sankyo Co Ltd Anticuerpos anti-Siglec-15
SE539197C2 (en) * 2015-09-15 2017-05-09 Nida Tech Sweden Ab Positioning system and device comprising an electronic ink display
EP3405785B1 (en) * 2016-01-23 2020-04-29 Biocon Limited Bio-analytical method for insulin analogues

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179337A (en) 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
GB2051574B (en) 1979-05-10 1984-01-18 Kyoto Pharma Ind Adjuvant for promoting absorption of pharmacologically active substances through the rectum
IL68769A (en) 1983-05-23 1986-02-28 Hadassah Med Org Pharmaceutical compositions containing insulin for oral administration
US5182258A (en) 1989-03-20 1993-01-26 Orbon Corporation Systemic delivery of polypeptides through the eye
US5321095A (en) 1993-02-02 1994-06-14 Enzon, Inc. Azlactone activated polyalkylene oxides
US5359030A (en) 1993-05-10 1994-10-25 Protein Delivery, Inc. Conjugation-stabilized polypeptide compositions, therapeutic delivery and diagnostic formulations comprising same, and method of making and using the same
TW402506B (en) 1993-06-24 2000-08-21 Astra Ab Therapeutic preparation for inhalation
GB9417524D0 (en) 1994-08-31 1994-10-19 Cortecs Ltd Pharmaceutical compositions
GB9516268D0 (en) 1995-08-08 1995-10-11 Danbiosyst Uk Compositiion for enhanced uptake of polar drugs from the colon
US6011008A (en) 1997-01-08 2000-01-04 Yissum Research Developement Company Of The Hebrew University Of Jerusalem Conjugates of biologically active substances
IT1291623B1 (it) 1997-04-18 1999-01-11 Bracco Spa Procedimento per la coniugazione di chelanti con molecole contenenti gruppi amminici
JP3406244B2 (ja) * 1999-04-30 2003-05-12 伊藤ハム株式会社 新規な融合蛋白質からの組み換えインスリンの製造方法
US6309633B1 (en) 1999-06-19 2001-10-30 Nobex Corporation Amphiphilic drug-oligomer conjugates with hydroyzable lipophile components and methods for making and using the same
US6828297B2 (en) 2001-06-04 2004-12-07 Nobex Corporation Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US7312192B2 (en) * 2001-09-07 2007-12-25 Biocon Limited Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
US6770625B2 (en) * 2001-09-07 2004-08-03 Nobex Corporation Pharmaceutical compositions of calcitonin drug-oligomer conjugates and methods of treating diseases therewith
EP1430082B1 (en) * 2001-09-07 2009-10-28 Biocon Limited Methods of synthesizing insulin polypeptide-oligomer conjugates, and proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
EP1563075A4 (en) * 2002-11-12 2006-09-06 Ckd Bio Corp HUMANINSULIN EXPRESSIVE PLASMIDE AND METHOD FOR THE PRODUCTION OF HUMANINSULIN THEREWITH
EP1660047B1 (en) * 2003-08-13 2013-11-27 Biocon Limited Micro-particle fatty acid salt solid dosage formulations for therapeutic agents
US7977454B2 (en) * 2005-07-08 2011-07-12 Biocon Limited Preparation of insulin conjugates

Also Published As

Publication number Publication date
KR20080067625A (ko) 2008-07-21
PL1934252T3 (pl) 2015-10-30
BRPI0520622B1 (pt) 2021-04-13
DK1934252T3 (en) 2015-08-31
EP1934252B1 (en) 2015-06-24
US8058391B2 (en) 2011-11-15
KR101269540B1 (ko) 2013-05-30
EP1934252A1 (en) 2008-06-25
US20110020871A1 (en) 2011-01-27
IL190666A0 (en) 2008-11-03
CN101291952B (zh) 2016-02-03
WO2007043059A1 (en) 2007-04-19
BRPI0520622A2 (pt) 2009-05-19
ES2546016T3 (es) 2015-09-17
JP2009511039A (ja) 2009-03-19
PT1934252E (pt) 2015-10-12
MX2008004674A (es) 2008-11-12
EP1934252A4 (en) 2010-07-14
IL190666A (en) 2014-08-31
JP5047978B2 (ja) 2012-10-10
CN101291952A (zh) 2008-10-22

Similar Documents

Publication Publication Date Title
BRPI0520622A2 (pt) processo para o preparo de conjugados de insulina
BRPI0407967A (pt) processo de uma etapa para a preparação de derivados anticonvulsivantes
BR112012006406A2 (pt) "processo para a fabrição de n-acilbifenil alanina"
BR0214260A (pt) Processo para a preparação de catalisador de hidrocianação e processo para a produção de cloreto de nìquel anidro
BR0307721A (pt) Processo para preparação de derivados de indolinona
UA89830C2 (ru) Кристаллическая модификация iv пираклостробина, способы ее получения, композиция для защиты растений и применение
MY148758A (en) Crystalline forms of aliskiren hemifumarate
CY1112009T1 (el) Παρασκευη συζυγων ινσουλινης
TW200716203A (en) Manufacturing process for tigecycline
MX2008008120A (es) Nuevos compuestos y metodos para formar taxanos y uso de los mismos.
SG195161A1 (en) Method for producing proline compound
PT1272495E (pt) Processo para a preparacao de cefoperazona de sodio altamente cristalina
USD607493S1 (en) Type font
TW200738650A (en) Process for synthesis of aryloxy diaminopyrimidines
NZ589496A (en) Processes and compounds for the preparation of normorphinans
BRPI0606659A2 (pt) processos para a preparação de álcoois aminoetoxibenzìlicos
EP1757597A4 (en) PREPARATION FOR 2-OXO-1-PHENYL-3-OXABICYCLO [3.1.0] HEXANE
SI1885707T1 (sl) Postopek za äśiĺ äśenje 10-deacetilbakatina iii iz 10-deacetil-2-debenzoil-2-pentenoilbakatina iii
TW200630697A (en) Backplate applied in backlight module
BR0315892A (pt) Processo contìnuo para a preparação de derivados de sulfamato de frutopiranose
PT1861352E (pt) Processo para a preparação de derivados de ácido 3- fenilpropiónico opticamente activos e respectivos produtos secundários
BRPI0514076A (pt) processo de preparação da n-aminopiperidina e de seus sais
BR0313467A (pt) Processo para preparação de hidroxiindolilglioxilamidas de alta pureza
WO2006137348A3 (en) Production process of nucleus-halogenated methylbenzyl alcohol
TH31891S1 (th) กรอบหน้าปัดนาฬิกาข้อมือ

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 13/10/2005, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME MEDIDA CAUTELAR DE 07/04/2021 - ADI 5.529/DF

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 13/10/2005 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 18A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2744 DE 08-08-2023 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.